ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

10,328Medicare Part D Prescriptions Filled, Including Refills

Rank: 151 out of 944

$631K Total Retail Price of All Prescriptions

Rank: 98 out of 944

431 Patients Receiving at Least One Drug in Part D
60%Patients 65 Years and Older
63% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Wisconsin
Lower avg

Schedule Two
Controlled Substances

15% of this provider’s 431 patients filled at least one prescription for a schedule two drug, compared to an average of 6%.

Schedule Three
Controlled Substances

18% of this provider’s 431 patients filled at least one prescription for a schedule three drug, compared to an average of 9%.

Risky Drugs to Seniors

1% of this provider’s 5,651 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

23% of this provider’s prescriptions were for brand-name drugs, compared to an average of 23%.

Prescription Price

$61 was the average price of a prescription from this provider, compared to $55 among peers.

Prescriptions per Patient

24 is the average number of prescriptions (including refills) per patient, compared to an average of 20.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Wisconsin
AMLODIPINE BESYLATE 479 281 1 5
SIMVASTATIN 436 259 2 1
OMEPRAZOLE 336 165 3 4
LISINOPRIL 325 221 4 3
LEVOTHYROXINE SODIUM 268 200 5 2
FUROSEMIDE 254 155 6 6
METOPROLOL TARTRATE 206 127 7 8
HYDROCHLOROTHIAZIDE 205 118 8 9
LOSARTAN POTASSIUM 203 162 9 16
HYDROCODONE-ACETAMINOPHEN 196 77 S3 10 10
METFORMIN HCL 179 66 11 12
METOPROLOL SUCCINATE 168 81 12 14
FLUTICASONE PROPIONATE 165 83 13 40
ATORVASTATIN CALCIUM 165 86 13 13
WARFARIN SODIUM 154 139 15 7
ATENOLOL 146 127 16 11
OXYCODONE-ACETAMINOPHEN 142 38 S2 17 62
ALLOPURINOL 131 85 18 22
GABAPENTIN 117 46 19 18
POTASSIUM CHLORIDE 111 67 20 15
OXYCODONE HCL 97 47 S2 21 50
MORPHINE SULFATE ER 97 38 S2 21 80
CLONIDINE HCL 96 32 23 67
POLYETHYLENE GLYCOL 3350 96 45 23 41
NEXIUM 96 24 23 53
PRAVASTATIN SODIUM 91 54 26 17
CYCLOBENZAPRINE HCL 91 14 R 26 86
COMBIVENT 90 50 28 107
FENOFIBRATE 85 26 29 58
PROAIR HFA 84 17 30 56
PANTOPRAZOLE SODIUM 82 48 31 34
METFORMIN HCL ER 82 22 31 49
LOVASTATIN 81 62 33 26
CITALOPRAM HBR 77 41 34 19
HYDRALAZINE HCL 77 42 34 87
SERTRALINE HCL 76 30 36 23
BENAZEPRIL HCL 74 41 37 66
TRIAMTERENE-HCTZ 73 64 38 33
ADVAIR DISKUS 71 27 39 31
TAMSULOSIN HCL 68 57 40 27
LANTUS SOLOSTAR 67 20 41 61
OXYCONTIN 67 41 S2 41 92
LOSARTAN-HYDROCHLOROTHIAZIDE 66 52 43 54
TRAMADOL HCL 66 28 43 21
CRESTOR 62 46 45 28
OXYCODONE HCL-ACETAMINOPHEN 61 15 S2 46 127
CLOPIDOGREL 61 41 46 36
DIOVAN 60 22 48 38
IBUPROFEN 59 27 49 140
ZOLPIDEM TARTRATE 59 37 49 25
PEN NEEDLE 58 18 51 100
FAMOTIDINE 58 0 51 74
PLAVIX 58 47 51 55
INSULIN SYRINGE 58 38 51 121
ENALAPRIL MALEATE 52 38 55 43
SPIRIVA 51 26 56 65
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on July 8, 2007.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.